Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis

Angiogenesis

Volumn 11, Issue 1, 2008, Pages 31-39

  Geretti, Elena ^a   Shimizu, Akio ^a   Klagsbrun, Michael ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Angiogenesis; Axon guidance; Cancer; Neuropilin; Semaphorin; Structure; VEGF

Indexed keywords

AMINO ACID; NEUROPILIN; NRP1 PROTEIN; NRP2 PROTEIN; SEMAPHORIN; SEMAPHORIN 3A; SEMAPHORIN 3F; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 165;

ANGIOGENESIS; BINDING SITE; EXTRACELLULAR MATRIX; GENE CONTROL; GENE FUNCTION; GENE STRUCTURE; LIGAND BINDING; MUTAGENESIS; NERVE FIBER; NONHUMAN; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; RETINA DISEASE; REVIEW; RODENT; TUMOR; ZEBRA FISH;

ANIMALS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROPILINS; PROTEIN BINDING; SEMAPHORINS; VASCULAR ENDOTHELIAL GROWTH FACTORS;

DANIO RERIO;

EID: 41049099329     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10456-008-9097-1     Document Type: Review

References (96)

1. Fujisawa H et al (1997) Roles of a neuronal cell-surface molecule, neuropilin, in nerve fiber fasciculation and guidance. Cell Tissue Res 290(2):465-470
2. Klagsbrun M, Takashima S, Mamluk R (2002) The role of neuropilin in vascular and tumor biology. Adv Exp Med Biol 515:33-48
3. Fujisawa H (2004) Discovery of semaphorin receptors, neuropilin and plexin, and their functions in neural development. J Neurobiol 59(1):24-33
4. Eichmann A, Makinen T, Alitalo K (2005) Neural guidance molecules regulate vascular remodeling and vessel navigation. Genes Dev 19(9):1013-1021
5. Klagsbrun M, Eichmann A (2005) A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis. Cytokine Growth Factor Rev 16(4-5):535-548
6. Takagi S et al (1987) Specific cell surface labels in the visual centers of Xenopus laevis tadpole identified using monoclonal antibodies. Dev Biol 122(1):90-100
7. Takagi S et al (1991) The A5 antigen, a candidate for the neuronal recognition molecule, has homologies to complement components and coagulation factors. Neuron 7(2):295-307
8. Kolodkin AL et al (1997) Neuropilin is a semaphorin III receptor. Cell 90(4):753-762
9. Chen H et al (1997) Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III. Neuron 19(3):547-559
10. He Z, Tessier-Lavigne M (1997) Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 90(4):739-751
11. Soker S et al (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92(6):735-745
12. Bielenberg DR, Klagsbrun M (2007) Targeting endothelial and tumor cells with semaphorins. Cancer Metastasis Rev 26(3-4):421-431
13. Ellis LM (2006) The role of neuropilins in cancer. Mol Cancer Ther 5(5):1099-1107
14. Geretti E, Klagsbrun M (2007) Neuropilins, novel targets for anti-angiogenesis therapies. Cell Adhes Migr 1(2):56-61
15. Pan Q et al (2007) Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. Cancer Cell 11(1):53-67
16. Rosenfeld PJ et al (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355(14):1419-1431
17. Giger RJ et al (1998) Neuropilin-2 is a receptor for semaphorin IV: insight into the structural basis of receptor function and specificity. Neuron 21(5):1079-1092
18. Nakamura F, Goshima Y (2002) Structural and functional relation of neuropilins. Adv Exp Med Biol 515:55-69
19. Nakamura F et al (1998) Neuropilin-1 extracellular domains mediate semaphorin D/III-induced growth cone collapse. Neuron 21(5):1093-1100
20. Renzi MJ et al (1999) A dominant negative receptor for specific secreted semaphorins is generated by deleting an extracellular domain from neuropilin-1. J Neurosci 19(18):7870-7880
21. Roth L et al (2007) Transmembrane domain interactions control biological functions neuropilin-1. Mol Biol Cell 19(2):646-654
22. Rossignol M, Gagnon ML, Klagsbrun M (2000) Genomic organization of human neuropilin-1 and neuropilin-2 genes: identification and distribution of splice variants and soluble isoforms. Genomics 70(2):211-222
23. Cackowski FC et al (2004) Identification of two novel alternatively spliced Neuropilin-1 isoforms. Genomics 84(1):82-94
24. Gagnon ML et al (2000) Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: in vivo expression and antitumor activity. Proc Natl Acad Sci USA 97(6):2573-2578
25. Gluzman-Poltorak Z et al (2000) Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165. J Biol Chem 275(24):18040-18045
26. Gu C et al (2002) Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165. J Biol Chem 277(20):18069-18076
27. Karpanen T et al (2006) Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. Faseb J 20(9):1462-1472
28. Makinen T et al (1999) Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1. J Biol Chem 274(30):21217-21222
29. Wise LM et al (2003) Viral vascular endothelial growth factors vary extensively in amino acid sequence, receptor-binding specificities, and the ability to induce vascular permeability yet are uniformly active mitogens. J Biol Chem 278(39):38004-38014
30. Sulpice E et al (2008) Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity. Blood 111(4):2036-2045
31. West DC et al (2005) Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2. J Biol Chem 280(14):13457-13464
32. Geretti E et al (2007) Site-directed mutagenesis in the B-neuropilin-2 domain selectively enhances its affinity to VEGF165, but not to semaphorin 3F. J Biol Chem 282(35):25698-25707
33. Mamluk R et al (2002) Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain. J Biol Chem 277(27):24818-24825
34. Vander Kooi CW et al (2007) Structural basis for ligand and heparin binding to neuropilin B domains. Proc Natl Acad Sci USA 104(15):6152-6157
35. Miao HQ et al (1999) Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol 146(1):233-242
36. Appleton BA et al (2007) Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding. Embo J 26(23):4902-4912
37. Lee CC et al (2003) Crystal structure of the human neuropilin-1 b1 domain. Structure 11(1):99-108
38. Gu C et al (2003) Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev Cell 5(1):45-57
39. von Wronski MA et al (2006) Tuftsin binds neuropilin-1 through a sequence similar to that encoded by exon 8 of vascular endothelial growth factor. J Biol Chem 281(9):5702-5710
40. Soker S et al (1996) Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain. J Biol Chem 271(10):5761-5767
41. Soker S et al (1997) Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165. J Biol Chem 272(50):31582-31588
42. Pan Q et al (2007) Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting. J Biol Chem 282(33):24049-24056
43. Shraga-Heled N et al (2007) Neuropilin-1 and neuropilin-2 enhance VEGF121 stimulated signal transduction by the VEGFR-2 receptor. Faseb J 21(3):915-926
44. Bates DO et al (2002) VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res 62(14):4123-4131
45. Cebe Suarez S et al (2006) A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2. Cell Mol Life Sci 63(17):2067-2077
46. Bachelder RE et al (2001) Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res 61(15):5736-5740
47. Bachelder RE, Wendt MA, Mercurio AM (2002) Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 62(24):7203-7206
48. Hu B. et al (2007) Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway. Oncogene 26(38):5577-5586
49. Wang L et al (2003) Neuropilin-1-mediated vascular permeability factor/vascular endothelial growth factor-dependent endothelial cell migration. J Biol Chem 278(49):48848-48860
50. Cai H, Reed RR (1999) Cloning and characterization of neuropilin-1-interacting protein: a PSD-95/Dlg/ZO-1 domain-containing protein that interacts with the cytoplasmic domain of neuropilin-1. J Neurosci 19(15):6519-6527
51. Chittenden TW et al (2006) Selective regulation of arterial branching morphogenesis by synectin. Dev Cell 10(6):783-795
52. Gao Y et al (2000) Synectin, syndecan-4 cytoplasmic domain binding PDZ protein, inhibits cell migration. J Cell Physiol 184(3):373-379
53. Wang L, Mukhopadhyay D, Xu X (2006) C terminus of RGS-GAIP-interacting protein conveys neuropilin-1-mediated signaling during angiogenesis. Faseb J 20(9):1513-1515
54. Goishi K, Klagsbrun M (2004) Vascular endothelial growth factor and its receptors in embryonic zebrafish blood vessel development. Curr Top Dev Biol 62:127-152
55. Lee P et al (2002) Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish. Proc Natl Acad Sci USA 99(16):10470-10475
56. Eichmann A et al (2005) Vascular development: from precursor cells to branched arterial and venous networks. Int J Dev Biol 49(2-3):259-267
57. Herzog Y et al (2001) Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins. Mech Dev 109(1):115-119
58. Yaniv K et al (2006) Live imaging of lymphatic development in the zebrafish. Nat Med 12(6):711-716
59. Yuan L et al (2002) Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 129(20):4797-4806
60. Kitsukawa T et al (1995) Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development 121(12):4309-4318
61. Kawasaki T et al (1999) A requirement for neuropilin-1 in embryonic vessel formation. Development 126(21):4895-4902
62. Takashima S et al (2002) Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc Natl Acad Sci USA 99(6):3657-3662
63. Chan J et al (2002) Dissection of angiogenic signaling in zebrafish using a chemical genetic approach. Cancer Cell 1(3):257-267
64. Mukouyama YS et al (2005) Peripheral nerve-derived VEGF promotes arterial differentiation via neuropilin 1-mediated positive feedback. Development 132(5):941-952
65. Miao HQ et al (2000) Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. Faseb J 14(15):2532-2539
66. Parikh AA et al (2004) Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis. Am J Pathol 164(6):2139-2151
67. Wey JS et al (2005) Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells. Br J Cancer 93(2):233-241
68. Hong TM et al (2007) Targeting neuropilin 1 as an antitumor strategy in lung cancer. Clin Cancer Res 13(16):4759-4768
69. Baba T et al (2007) Neuropilin-1 promotes unlimited growth of ovarian cancer by evading contact inhibition. Gynecol Oncol 105(3):703-711
70. Handa A et al (2000) Neuropilin-2 expression affects the increased vascularization and is a prognostic factor in osteosarcoma. Int J Oncol 17(2):291-295
71. Hansel DE et al (2004) Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract. Am J Surg Pathol 28(3):347-356
72. Kawakami T et al (2002) Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma. Cancer 95(10):2196-2201
73. Kreuter M et al (2006) Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemia. Leukemia 20(11):1950-1954
74. Lantuejoul S et al (2003) Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines. J Pathol 200(3):336-347
75. Latil A et al (2000) VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms. Int J Cancer 89(2):167-171
76. Osada H et al (2004) Overexpression of the neuropilin 1 (NRP1) gene correlated with poor prognosis in human glioma. Anticancer Res 24(2B):547-552
77. Sanchez-Carbayo M et al (2003) Gene discovery in bladder cancer progression using cDNA microarrays. Am J Pathol 163(2):505-516
78. Vanveldhuizen PJ et al (2003) Differential expression of neuropilin-1 in malignant and benign prostatic stromal tissue. Oncol Rep 10(5):1067-1071
79. Broholm H, Laursen H (2004) Vascular endothelial growth factor (VEGF) receptor neuropilin-1's distribution in astrocytic tumors. Apmis 112(4-5):257-263
80. Ochiumi T et al (2006) Neuropilin-1 is involved in regulation of apoptosis and migration of human colon cancer. Int J Oncol 29(1):105-116
81. Osada R et al (2006) Expression of semaphorins, vascular endothelial growth factor, and their common receptor neuropilins and alleic loss of semaphorin locus in epithelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphorin is a poor prognostic factor in ovarian carcinomas. Hum Pathol 37(11):1414-1425
82. Klein R et al (2007) Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 114(2):253-262
83. Wang JJ et al (2007) The LOC387715 Polymorphism, inflammatory markers, smoking, and age-related macular degeneration a population-based case-control study. Ophthalmology
84. Fletcher EC, Chong NV (2008) Looking beyond Lucentis on the management of macular degeneration. Eye. doi: 10.1038/sj.eye.6703008
85. Lien S, Lowman HB (2008) Therapeutic anti-VEGF antibodies. Handb Exp Pharmacol 181:131-150
86. Ishida S et al (2000) Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 41(7):1649-1656
87. Sekido Y et al (1996) Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns. Proc Natl Acad Sci USA 93(9):4120-4125
88. Tse C et al (2002) Human Semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line. Cancer Res 62(2):542-546
89. Castro-Rivera E et al (2004) Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect. Proc Natl Acad Sci USA 101(31):11432-11437
90. Kessler O et al (2004) Semaphorin-3F is an inhibitor of tumor angiogenesis. Cancer Res 64(3):1008-1015
91. Bielenberg DR et al (2004) Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. J Clin Invest 114(9):1260-1271
92. Futamura M et al (2007) Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p21.3, in p53-regulated tumor angiogenesis suppression. Cancer Res 67(4):1451-1460
93. Jia H et al (2006) Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signaling. J Biol Chem 281(19):13493-13502
94. Siemion IZ, Kluczyk A (1999) Tuftsin: on the 30-year anniversary of Victor Najjar's discovery. Peptides 20(5):645-674
95. Starzec A et al (2006) Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1. Life Sci 79(25):2370-2381
96. Starzec A et al (2007) Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex. Peptides 28(12):2397-2402